PM-SCL autoantibody positive scleroderma with polymyositis (mechanic's hand: Clinical aid in the diagnosis)

Journal of the European Academy of Dermatology and Venereology

Volumn 18, Issue 3, 2004, Pages 356-359

  Török, Laslo ^a   Danko K ^b   Cserni, G ^a   Szucs G ^b  

^a 1st Department of Internal Medicine   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

'Mechanic's hands'; Dermatomyosis; Interstitial lung disease; PM SCL autoantibody; Scleroderma

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; METHYLPREDNISOLONE;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; COMORBIDITY; DERMADROME; DERMATOMYOSITIS; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; PREDICTION; PRIORITY JOURNAL; SCLERODERMA; SKIN MANIFESTATION;

AUTOANTIBODIES; BIOPSY, NEEDLE; DERMATOMYOSITIS; ECZEMA; FEMALE; FOLLOW-UP STUDIES; HAND DERMATOSES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; RISK ASSESSMENT; SCLERODERMA, LOCALIZED; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 2442514394     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2004.00868.x     Document Type: Article

References (14)

1. Blaszcyk M, Jablonska S, Szymanska-Agiello W et al. Childhood scleromyositis: an overlap syndrome associated with PM-Scl antibody. Pediatr Dermatol 1991; 1: 1-8.
2. Jablonska S, Blaszcyk M. Scleromyositis: a scleroderma/polymyositis overlap syndrome. Clin Rheumatol 1998; 17: 465-467.
3. Jablonska S, Blaszcyk M. Scleroderma overlap syndromes. Adv Exp Med Biol 1999, 45585-45592.
4. Genth E, Mireau R, Geneczky P et al. Immunogenetic associations of scleroderma related antinuclear antibodies. Arthritis Rheum 1999; 33: 657-665.
5. Grau JM, Miró O, Pedrol E et al. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. J Rheumatol 1996; 23: 1921-1926.
6. Spiera R, Kagen L. Extramuscular manifestations in idiopathic inflammatory myopathies. Curr Opin Rheum 1998; 10: 556-561.
7. Weinracuh J, Hunzelmann N. Dermatomyositis: Die Bedeutung Myositis-assozierter Autoantikörper für Diagnose, Klinik und Prognose. Z Hautkr 2002; 77: 6-12.
8. Oddis CV, Okano Y, Rudert WA et al. Serum autoantibody to the nucleolar antigen PM-Scl: clinical and immunogenetic associations. Arthritis Rheum 1992; 35: 1211-1217.
9. Genth E, Mireau R. Diagnostische Bedeutung Sclerodermie-und Myositis-Assozierter Autoantikörper. Z Rheumatol 1995; 1: 39-49.
10. Haitas-Haase M. PM-SCL-Antikörper positive Sclerodermie mit Polymyositis (Skleromyositis). Z Hautkr 2000; 75: 707-708.
11. Stahl NI, Klippel JH, Decker JL. A cutaneous lesion associated with myositis. Ann Intern Med 1979; 4: 577-579.
12. Mitra D, Lovell CL, Macleod TIF et al. Clinical and histological features of 'mechanic's hands' in a patient with antibodies to Jo-1: a case report. Clin Exp Dermatol 1994; 19: 146-148.
13. Herrero C, Grau JM, Lecha M. Anti-synthetase syndrome. J Eur Acad Dermatol Venereol 2000; 14 (Suppl. 1): 17.
14. Schöffel A, Schöffel D. Pm-Scl-Assoziertes Overlap-Syndrom (Dermatomyositis/Sklerodermie). Akt Dermatol 2000; 26: 374-377.